Medicare Enrolled
Dr. Mobeen Mazhar, M.D.
Cardiovascular Disease · Cypress, TX
Practice pattern: Cardiac & Remote
— Practice combining cardiac and remote services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mazhar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mazhar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mazhar
Dr. Mobeen Mazhar is a cardiovascular disease specialist in Cypress, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mazhar performed 4,800 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mazhar received a total of $8,960 from 41 pharmaceutical and/or device companies across 443 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mazhar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 20% volume in TX
$8,960 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,800
Medicare services
Top 20% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,349 | $61 | $250 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
463 | $31 | $96 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
441 | $130 | $780 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
356 | $42 | $110 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
349 | $48 | $264 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
345 | $38 | $118 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
279 | $38 | $132 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
209 | $9 | $80 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
196 | $162 | $208 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
195 | $343 | $2,200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
190 | $64 | $250 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
121 | $137 | $450 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
98 | $102 | $260 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
96 | $80 | $350 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
44 | $192 | $1,000 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
28 | $10 | $45 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
21 | $196 | $1,000 |
| Cardiac catheterization | 20 | $202 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.6% high complexity
25.8% medium
64.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,960
Total received (2018-2024)
Avg $1,280/year across 7 years
Top 35% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
443
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,455
2023
$1,112
2022
$1,427
2021
$993
2020
$975
2019
$1,323
2018
$1,674
Payments by company (2024)
Amgen Inc.
$234
Novartis Pharmaceuticals Corporation
$198
Boston Scientific Corporation
$184
Kiniksa Pharmaceuticals International, plc
$118
Merck Sharp & Dohme LLC
$115
Philips North America LLC
$112
PFIZER INC.
$78
Janssen Pharmaceuticals, Inc
$67
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$63
Esperion Therapeutics, Inc.
$58
AGEPHA Pharma FZ LLC
$37
Actelion Pharmaceuticals US, Inc.
$36
E.R. Squibb & Sons, L.L.C.
$33
Novo Nordisk Inc
$29
Regeneron Healthcare Solutions, Inc.
$28
AstraZeneca Pharmaceuticals LP
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$18
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$997
Novartis Pharmaceuticals Corporation
$750
Abbott Laboratories
$736
Janssen Pharmaceuticals, Inc
$735
E.R. Squibb & Sons, L.L.C.
$574
Boston Scientific Corporation
$547
Lundbeck LLC
$456
Merck Sharp & Dohme LLC
$451
Esperion Therapeutics, Inc.
$384
SANOFI-AVENTIS U.S. LLC
$338
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$336
Novo Nordisk Inc
$305
PFIZER INC.
$244
Actelion Pharmaceuticals US, Inc.
$238
Amarin Pharma Inc.
$235
AstraZeneca Pharmaceuticals LP
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$196
Kiniksa Pharmaceuticals International, plc
$118
Philips North America LLC
$112
ARALEZ PHARMACEUTICALS US INC.
$108
BIOTRONIK INC.
$94
PORTOLA PHARMACEUTICALS, INC.
$90
Arbor Pharmaceuticals, Inc.
$83
AtriCure, Inc.
$77
Azurity Pharmaceuticals, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$70
ARBOR PHARMACEUTICALS, INC.
$48
Astellas Pharma US Inc
$46
Allergan Inc.
$39
Medtronic Vascular, Inc.
$37
AGEPHA Pharma FZ LLC
$37
Impulse Dynamics (USA) Inc.
$29
Edwards Lifesciences Corporation
$22
Althera Pharmaceuticals LLC
$21
Medtronic, Inc.
$20
Lilly USA, LLC
$18
Adhera Therapeutics, Inc.
$17
Chiesi USA, Inc.
$17
Gilead Sciences, Inc.
$17
SCPHARMACEUTICALS INC.
$15
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
(BH4) IGT Devices Undivided · ANDEXXA · Accent Pacemaker · Arcalyst · BEVYXXA · BRILINTA · BYSTOLIC · BodyGuardian · CAMZYOS · CARDENE · CHANTIX · CONFIRM RX · CareLink · Connectivity and Remote care · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FUROSCIX · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Horizant · ICDs · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LINZESS · LODOCO · LifeVest · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRESTALIA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Repatha · Resolute · Roszet · Saxenda · UPTRAVI · VERQUVO · VIGILANT · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE V · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
199
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mazhar is a cardiac & remote specialist, with above-average Medicare volume (top 20% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mazhar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mazhar performed 1,349 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mazhar receive payments from pharmaceutical companies?
Yes. Dr. Mazhar received a total of $8,960 from 41 companies across 443 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mazhar's costs compare to other cardiologists in Cypress?
Dr. Mazhar's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mazhar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cypress
Browse cardiologists in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology